excel-based program (Cylex Inc)
90
Structured Review
Cylex Inc
excel-based program
Excel Based Program, supplied by Cylex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/excell+based+computer+program/excel+based+program/pmc02911756-71-17-21
Average 90 stars, based on 1 article reviews
Excel Based Program, supplied by Cylex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/excell+based+computer+program/excel+based+program/pmc02911756-71-17-21
Average 90 stars, based on 1 article reviews
excel-based program - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipients. Article Snippet: Previous studies have shown that intracellular adenosine triphosphate (iATP) in activated CD4 T cells in vitro may identify patients at risk of infection or rejection posttransplantation.. In this study, we evaluated whether this test could identify the level of risk in 656 renal transplant recipients (RTRs) with good and stable graft function.. Therefore, 1095 blood samples from RTRs and 200 from healthy blood donors (normal controls [NCs]) were collected in 2 years and analyzed using the Cylex ImmuKnow assay (Cylex, Inc., Columbia, MD, USA). Article Title: CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study Article Snippet: The concentration of Article Title: Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Article Snippet: Objective.. The immune monitoring of transplant patients may allow us to minimize adverse events of immunosuppression and predict risks of rejection.. Herein we have evaluated the capacity of an immune cell function assay to predict episodes of rejection and infections as well as its correlation with immunosuppressive drug trough levels and CD4, CD8, CD25, and DR cell counts. |